US Map / Arizona
State AZ

Clinical Trials in Arizona

Arizona is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Arizona and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 242 actively recruiting studies with Arizona sites out of 242 registered in total. The busiest research areas in Arizona are Solid Tumor, Prostate Cancer, Obesity. Leading sponsors running trials in the state include Mayo Clinic, University of Arizona, AstraZeneca. By stage, Arizona trials break down as Phase 1 (37), Phase 2 (77), Phase 3 (80), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
242
Recruiting Now
242
← Back to US Map
Top Conditions in Arizona
Solid Tumor (6)Prostate Cancer (6)Obesity (6)Colorectal Cancer (4)Multiple Myeloma (3)Cancer (3)Advanced Solid Tumor (3)Developmental Language Disorder (3)Overweight (3)Colorectal Neoplasms (3)Carcinoma, Non-Small-Cell Lung (3)Graves' Disease (3)

Frequently Asked Questions — Clinical Trials in Arizona

How many clinical trials are currently recruiting in Arizona?
ClinicalMetric currently tracks 242 actively recruiting clinical trials with at least one location in Arizona. The total number of registered studies—including active but not currently enrolling trials—is 242. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Arizona?
Arizona hosts clinical trials across a broad range of medical conditions, including Solid Tumor, Prostate Cancer, Obesity, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Arizona serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Arizona?
To join a clinical trial in Arizona, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Arizona maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Arizona

NCT05786924 Phase 1, Phase 2
Recruiting
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Condition
Non-small Cell Lung Cancer
Enrollment
554 pts
Location
United States, Australia, China
Sponsor
Institut de Recherches Interna
View Trial →
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07722546 Phase 2
Recruiting
A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Sa...
Condition
Graves' Disease
Enrollment
60 pts
Location
United States, Puerto Rico
Sponsor
Biogen
View Trial →
NCT06136559 Phase 3
Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of I...
Condition
Chronic Lymphocytic Leukemia
Enrollment
1,200 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07611110 Phase 3
Recruiting
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-re...
Condition
Metastatic Castration-resistant Prostate Cancer
Enrollment
670 pts
Location
United States, Australia, Austria
Sponsor
AstraZeneca
View Trial →
NCT03866382 Phase 2
Recruiting
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) ...
Condition
Bladder Adenocarcinoma
Enrollment
314 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07684144 Phase 3
Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of ...
Condition
Obesity
Enrollment
950 pts
Location
United States, Canada, Japan
Sponsor
Amgen
View Trial →
NCT05650632 Phase 1
Recruiting
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-3...
Condition
Multiple Myeloma
Enrollment
250 pts
Location
United States, Canada, Denmark
Sponsor
AbbVie
View Trial →
NCT05780957 N/A
Recruiting
Multi-Cancer Early Detection (MCED) of Firefighters
Condition
Cancer
Enrollment
2,000 pts
Location
United States
Sponsor
Vincere Cancer Center
View Trial →
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT07632001 N/A
Recruiting
Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers
Condition
Diabetic Foot Ulcers (DFUs)
Enrollment
180 pts
Location
United States
Sponsor
Reprise Biomedical, Inc.
View Trial →
NCT06419374 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With...
Condition
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Enrollment
1,800 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
View Trial →
NCT05270213 Phase 1
Recruiting
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Condition
Advanced Cancer
Enrollment
164 pts
Location
United States
Sponsor
Riboscience, LLC.
View Trial →
NCT05111288 N/A
Recruiting
Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia
Condition
Coronary Artery Disease
Enrollment
120 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT07589608 Phase 2
Recruiting
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone...
Condition
Overweight
Enrollment
400 pts
Location
United States
Sponsor
Eli Lilly and Company
View Trial →
NCT07484217 Phase 3
Recruiting
Clinical Assessment of Response in the Treatment of Depression With Daytime Slee...
Condition
Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms
Enrollment
508 pts
Location
United States
Sponsor
Axsome Therapeutics, Inc.
View Trial →
NCT07018323 Phase 2
Recruiting
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatme...
Condition
Graves' Disease
Enrollment
210 pts
Location
United States, Australia, Brazil
Sponsor
Immunovant Sciences GmbH
View Trial →
NCT06931821 N/A
Recruiting
Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Abl...
Condition
Sustained Monomorphic VT (MMVT)
Enrollment
360 pts
Location
United States
Sponsor
University of Arizona
View Trial →
NCT05329584 N/A
Recruiting
InSpace Accelerated Rehabilitation Study
Condition
Rotator Cuff Tears
Enrollment
160 pts
Location
United States
Sponsor
Stryker Endoscopy
View Trial →
NCT06422806 Phase 3
Recruiting
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone f...
Condition
Metastatic Dedifferentiated Liposarcoma
Enrollment
365 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07020819 Phase 3
Recruiting
An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as AN...
Condition
Guillain-Barre Syndrome
Enrollment
30 pts
Location
United States, Denmark, France
Sponsor
Annexon, Inc.
View Trial →
NCT05850234 Phase 1, Phase 2
Recruiting
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
Condition
Relapsed/Refractory Multiple Myeloma
Enrollment
232 pts
Location
United States
Sponsor
AstraZeneca
View Trial →
NCT06456593 Phase 2
Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active...
Condition
Moderately to Severely Active Crohn Disease
Enrollment
212 pts
Location
United States, Belgium, Czechia
Sponsor
Abivax S.A.
View Trial →
NCT05919511 N/A
Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Condition
cGVHD
Enrollment
1,500 pts
Location
United States
Sponsor
Incyte Corporation
View Trial →
NCT07169734 Phase 1, Phase 2
Recruiting
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Ad...
Condition
Cervical Squamous Cell Carcinoma
Enrollment
180 pts
Location
United States, France, Hong Kong
Sponsor
Alentis Therapeutics AG
View Trial →
Page 7 of 10 — 242 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology